Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical vascular organoid therapy promotes microvascular regeneration and functional recovery in porcine ischemic cardiomyopathy.

Stem cell reports·2026
Same author

Impact of leaflet stiffness in aortic valve neocuspidization in ex vivo biomechanical simulation.

JTCVS open·2026
Same author

A Translational Surgical Porcine Model for Postoperative Intra-Abdominal Adhesion Formation.

Journal of visualized experiments : JoVE·2026
Same author

Survival Benefit of Heart-Kidney Versus Heart Transplant With or Without Delayed Kidney Transplant.

Journal of the American Heart Association·2026
Same author

Glycidyl methacrylate and methacrylic anhydride characterization for silk fibroin methacrylation in tissue engineering.

Journal of materials chemistry. B·2025
Same author

Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy.

Stem cells translational medicine·2025

Related Experiment Video

Updated: Dec 6, 2025

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
11:32

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering

Published on: December 20, 2010

15.4K

Engineered biomaterials for heart disease.

Lyndsay Stapleton1, Yuanjia Zhu2, Yi-Ping Joseph Woo2

  • 1Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Cardiothoracic Surgery, Stanford University, Stanford, CA 94305, USA; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94305, USA.

Current Opinion in Biotechnology
|October 4, 2020
PubMed
Summary
This summary is machine-generated.

Novel engineered biomaterials offer new hope for treating ischemic heart disease, a leading cause of death. Innovations in vascular grafts and cardiac patches address critical challenges in cardiovascular interventions and heart failure treatment.

More Related Videos

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

8.1K
Creation of Cardiac Tissue Exhibiting Mechanical Integration of Spheroids Using 3D Bioprinting
04:40

Creation of Cardiac Tissue Exhibiting Mechanical Integration of Spheroids Using 3D Bioprinting

Published on: July 2, 2017

10.6K

Related Experiment Videos

Last Updated: Dec 6, 2025

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
11:32

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering

Published on: December 20, 2010

15.4K
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

8.1K
Creation of Cardiac Tissue Exhibiting Mechanical Integration of Spheroids Using 3D Bioprinting
04:40

Creation of Cardiac Tissue Exhibiting Mechanical Integration of Spheroids Using 3D Bioprinting

Published on: July 2, 2017

10.6K

Area of Science:

  • Biomaterials Science
  • Cardiovascular Medicine
  • Regenerative Medicine

Background:

  • Ischemic heart disease causes 10 million deaths annually, with significant challenges in small-diameter vessel access and long-term heart failure mortality.
  • Current treatments improve outcomes but face limitations in graft availability and patient survival rates.

Purpose of the Study:

  • To discuss novel methodologies for advancing vascular grafts, cardiac patches, and injectable drug delivery systems for ischemic heart disease.
  • To address limitations in current engineered biomaterials for myocardial ischemia therapeutics and interventions.

Main Methods:

  • Review of innovative approaches including bilayered conduits, acellular bioactive extracellular matrix (ECM) scaffolds, and protease-responsive hydrogel delivery platforms.
  • Discussion of the motivation for innovation in the field of engineered biomaterials.

Main Results:

  • Engineered biomaterials show promise in overcoming limitations of current cardiovascular interventions.
  • Novel technologies like ECM scaffolds and hydrogels offer potential for improved therapeutic delivery and tissue regeneration.

Conclusions:

  • Advancements in engineered biomaterials are crucial for addressing unmet needs in treating ischemic heart disease.
  • Further development of vascular grafts, cardiac patches, and drug delivery systems can significantly improve patient outcomes and reduce mortality.